Search BlogCatalog
7 results of 7Directory
HippocraTech: Medicine, Technology, Web 2.0
http://hippocratech.org
HippocraTech was developed with the intentions of providing information about the latest happenings in healthcare and technology to a general audience.
Scientific Misconduct Blog
http://scientific-misconduct.blogspot.com
Discussion of scientific misconduct and research ethics, particularly as it pertains to the pharmaceutical industry, academic bullying and the Monty Pythonesque functioning of drug regulators. Mostly a mixture of humour and sarcasm.
MONEY FOR PHARMACISTS
http://www.moneyforpharmacistsbymebymadhav.blogspot.com
THIS BLOG TELLS INDIAN PHARMA COMPANIES AT BSE AND THEIR MARKET GLANCE
The MedRep Zone
http://themedrepzone.blogspot.com/
The blog is composed of several chapters that will equip readers with knowledge of the pharmaceutical marketing and sales profession. This website is the accumulation of knowledge that I have assimilated from previous companies, professional contacts
structured settlement and attorney basics
http://structured-settlement-attorney.blogspot.com
structured settlement and attorney basics,tips,latest articles,news.tax attorney,vioxx settlements and more
Tim Llewellyn Photography
http://timllewellyn.wordpress.com/
Tim Llewellyn is a Boston-based photographer specializing in advertising, corporate and editorial photography. His client list includes Merck, Raytheon, Spalding, Harvard Business School, Vanity Fair, Boston Magazine and The Boston Globe Magazine
10 results of 488Blog Posts
The FDA: Friend or Foe?
About Cancer | December 17th 2009 by Pulsa Murah
The FDA – Friend or Foe?The Federal Drug Administration was originally founded to “protect” we, the people of the United States, from unscrupulous drug companies and “snake oil” salesmen. However, it has grown into a read more
SEP-INFO
Des Fourmis dans les Pat's | December 17th 2009 by Fourmipat
Merck Serono France a annoncé aujourd’hui le lancement d’un site internet grand public dédié à la sclérose en plaques (SEP): www.sep-info.fr. L’objectif de ce site est d’apporter des réponses aux patients en termes de compréhension de read more
Merck and J&J Land Deals; Biogen Idec, Not So Much
Free Health Matters Blog | December 17th 2009
You want deals? Read more here: Merck and J&J Land Deals; Biogen Idec, Not So Much read more
Further Discussion on the Second District’s Decision in In Re V…
Bailey Class Action Daily | December 17th 2009 by Matt Bailey
In the two previous posts I have focused on the Court's analysis regarding predominance (here and here). However, another material component of In Re Vioxx Class Cases, __ Cal. App. 4th __ (2009) was the Court’s finding with regard to the issue of read more
CLIMB: étude longitudinale sur la sclérose en plaques
Des Fourmis dans les Pat's | December 16th 2009 by Fourmipat
Merck Serono annonce une collaboration en recherche fondamentale et en recherche clinique sur la sclérose en plaques Merck Serono a annoncé aujourd'hui une collaboration stratégique avec le Brigham and Women's Hospital, hôpital universitaire amé read more
Second District Upholds Denial of Certification in In Re Vioxx Cl…
Bailey Class Action Daily | December 16th 2009 by Matt Bailey
On December 15, 2009, the Second District (Division 3) upheld the trial court's denial of class certification in In Re Vioxx Class Cases, __ Cal.App. 4th __ (2009). In that case, the plaintiffs sought recovery, on behalf of all persons and enti read more
Drug reimportation amendment fails in the Senate 51-48
referred resulting variability | December 15th 2009 by kayceebran
Senators Schumer and Gillibrand voted to defeat this amendment. Well, at least the Presidents deal with Big PHARMA is intact. This means Amercans will pay more for prescription drugs. But as a Merck Stockholder? I’ll sell my Merck stock t read more
Which Doctors Are Getting Paid By Glaxo, Lilly and Merck?
Health News and Videos | December 15th 2009 by Orshe Wilson
GlaxoSmithKline has become the latest big pharma company to disclose payments to health-care providers, listing 3,700 U.S. doctors and others who received a total of $14.6 million in speaking and consulting fees during the second quarter. read more
After Market News
Astrodunia | December 15th 2009 by Rajeev Prakash
Glenmark may settle with Merck on Cholestrol Drug, Merck may withdraw patent litigations against Glenmark, If case settled, Glenmark’s US revenue would get boost. JSW Energy sets issue price of Rs 100/share GMR to raise Rs 1,200 crore via stake sal read more
Oral bisphosphonates associated with reduced invasive breast canc…
Heart Health | December 15th 2009 by Manmeet
Findings from a prospective analysis of the Women’s Health Initiative showed that women taking oral bisphosphonates for osteoporosis were less likely to develop invasive breast cancer.A total of 2,216 of 151,592 postmenopausal women enrolled in th read more
1 result of 1Discussions
10 results of 380Social Search
BobbyDelray has updated their twitter:
freehealthmatters has posted a new entry on: Free Health Matters Blog
Merck and J&J Land Deals; Biogen Idec, Not So Much
You want deals? Read more here: Merck and J&J Land Deals; Biogen Idec, Not So Much
Read More »
innovation360 has updated their twitter:
BobbyDelray has updated their twitter:
OrsheWilson has posted a new entry on: Health News and Videos
Which Doctors Are Getting Paid By Glaxo, Lilly and Merck?
GlaxoSmithKline has become the latest big pharma company to disclose payments to health-care providers, listing 3,700 U.S. doctors and others who received a total of $14.6 million in speaking and con…
Read More »
macroaxis has updated their twitter:
macroaxis has posted a new entry on: Macroaxis Wealth Management Collaboration Platform and Community
New MD of Merck\'s India arm in saddle
Read More »
metaxab has posted a new entry on: Life Sciences Blog
University of California, San Francisco, researcher receives ASBMB-Merck Award
Story Summary: James A. Wells, professor and chairman of the department pharmaceutical chemistry at the University of California, San Francisco, and director of UCSFs small molecule discovery center,…
Read More »
newindian has posted a new entry on: Zamp BioTopics
University Of California, San Francisco, Researcher Receives ASBMB-Merck Award
James A. Wells, professor and chairman of the department pharmaceutical chemistry at the University of California, San Francisco, and director of UCSF’s small molecule discovery center, has been…
Read More »
newindian has posted a new entry on: Zamp Bionews
Merck KGaA Starts Stimuvax Phase III Study INSPIRE In Asian Patients With Advanced NSCLC
Merck KGaA announced the initiation of its multi-national Phase III study of the investigational therapeutic cancer vaccine Stimuvax® (BLP25 liposome vaccine) in Asian patients with advanced non-smal…
Read More »
Top 5 Shown | View Next 5 results
View All Results